Cargando…

Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis

AIMS: A recent double‐blind placebo‐controlled crossover 70‐day trial demonstrated that a fixed combination of dextromethorphan and quinidine (DM/Q) improves speech and swallowing function in most patients with amyotrophic lateral sclerosis. In this study, a subset of participants, many of whom did...

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, Jordan R., Allison, Kristen M., Cordella, Claire, Richburg, Brian D., Pattee, Gary L., Berry, James D., Macklin, Eric A., Pioro, Erik P., Smith, Richard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256051/ https://www.ncbi.nlm.nih.gov/pubmed/30152872 http://dx.doi.org/10.1111/bcp.13745

Ejemplares similares

Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis
por: Tabor Gray, Lauren, et al.
Publicado: (2023)

Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self‐report scale (Center for Neurologic Study Bulbar Function Scale)
por: Smith, R. A., et al.
Publicado: (2018)

Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect
por: Pioro, Erik P.
Publicado: (2014)

Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
por: Smith, Richard, et al.
Publicado: (2017)

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
por: Yunusova, Yana, et al.
Publicado: (2011)

Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
por: Khoury, Rita
Publicado: (2021)

Face and content validation of the amyotrophic lateral sclerosis—Bulbar dysfunction index (ALS-BDI)
por: Yunusova, Yana, et al.
Publicado: (2023)

Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
por: Tampi, Rajesh R, et al.
Publicado: (2020)

Predicting Early Bulbar Decline in Amyotrophic Lateral Sclerosis: A Speech Subsystem Approach
por: Rong, Panying, et al.
Publicado: (2015)

Bulbar and speech motor assessment in ALS: Challenges and future directions
por: Green, Jordan R., et al.
Publicado: (2013)

Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect
por: Schoedel, Kerri A, et al.
Publicado: (2014)

Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech Subsystems
por: Rong, Panying, et al.
Publicado: (2016)

Protocol for psychometric evaluation of the Amyotrophic Lateral Sclerosis - Bulbar Dysfunction Index (ALS-BDI): a prospective longitudinal study
por: Yunusova, Yana, et al.
Publicado: (2022)

Two Distinct Clinical Phenotypes of Bulbar Motor Impairment in Amyotrophic Lateral Sclerosis
por: Stipancic, Kaila L., et al.
Publicado: (2021)

An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions
por: Pattee, Gary L., et al.
Publicado: (2014)

A Study of Potential Pharmacokinetic and Pharmacodynamic Interactions between Dextromethorphan/Quinidine and Memantine in Healthy Volunteers
por: Pope, Laura E., et al.
Publicado: (2012)

Treatment of pseudobulbar affect in a mixed neurodegenerative disorder with compounded quinidine capsules and dextromethorphan cough syrup
por: Villeneuve, Yannick, et al.
Publicado: (2020)

Rate of speech decline in individuals with amyotrophic lateral sclerosis
por: Eshghi, Marziye, et al.
Publicado: (2022)

Misdiagnosis: Hypoglossal palsy mimicking bulbar onset amyotrophic lateral sclerosis
por: Goldstein, Eric D., et al.
Publicado: (2018)

Bulbar onset amyotrophic lateral sclerosis: A case report
por: Pudasaini, Prasamsa, et al.
Publicado: (2022)

Bulbar Onset Amyotrophic Lateral Sclerosis: A Case Report
por: Rai, Kabindra, et al.
Publicado: (2023)

PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
por: Hammond, Flora M., et al.
Publicado: (2016)

MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis
por: Donatelli, Graziella, et al.
Publicado: (2019)

Basilar invagination: A mimicker of bulbar-onset amyotrophic lateral sclerosis
por: Tan, Jason Seng Hong, et al.
Publicado: (2021)

Recurrent Lingual Abscess in an Elderly Female With Bulbar Amyotrophic Lateral Sclerosis
por: Carotenuto, Alessandro, et al.
Publicado: (2022)

Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
por: Hammond, Flora M., et al.
Publicado: (2016)

Clinical Features of Isolated Bulbar Palsy of Amyotrophic Lateral Sclerosis in Chinese Population
por: Zhang, Hua-Gang, et al.
Publicado: (2017)

How to increase noninvasive ventilation effectiveness in bulbar amyotrophic lateral sclerosis patients
por: Sancho, Jesus, et al.
Publicado: (2023)

Detecting bulbar amyotrophic lateral sclerosis (ALS) using automatic acoustic analysis
por: Simmatis, Leif, et al.
Publicado: (2023)

Therapeutic Approach of a High Functioning Individual With Traumatic Brain Injury and Subsequent Emotional Volatility With Features of Pathological Laughter and Crying With Dextromethorphan/Quinidine
por: Garcia-Baran, Dynela, et al.
Publicado: (2016)

Advanced magnetic resonance neuroimaging in bulbar and limb onset early amyotrophic lateral sclerosis
por: Vora, Maulik, et al.
Publicado: (2016)

Progress in respiratory management of bulbar complications of motor neuron disease/amyotrophic lateral sclerosis?
por: Simonds, Anita K
Publicado: (2017)

Agraphia in Bulbar-Onset Amyotrophic Lateral Sclerosis: Not Merely a Consequence of Dementia or Aphasia
por: Ichikawa, Hiroo, et al.
Publicado: (2008)

Squamous cell carcinoma of the base of the tongue mimicking bulbar-onset amyotrophic lateral sclerosis
por: Lin, Hsin-Pin, et al.
Publicado: (2020)

Disease duration of progression is helpful in identifying isolated bulbar palsy of amyotrophic lateral sclerosis
por: Zhang, Huagang, et al.
Publicado: (2021)

The Price of Quinidine
Publicado: (1922)

A Clinical Scale for Rating the Severity of Bulbar Lower Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis
por: Zoccolella, Stefano, et al.
Publicado: (2023)

The rostral to caudal gradient of clinical and electrophysiological features in sporadic amyotrophic lateral sclerosis with bulbar-onset
por: Liao, Song-Jie, et al.
Publicado: (2020)

Detecting Bulbar Involvement in Patients with Amyotrophic Lateral Sclerosis Based on Phonatory and Time-Frequency Features
por: Tena, Alberto, et al.
Publicado: (2022)

Bulbar Onset Amyotrophic Lateral Sclerosis in a COVID-19 Patient: A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ha5qcl7ps7r6bdt3mbsiund41l